SCHEMBL7014120

SCHEMBL7014120

c1cc2[nH]cc([C@H]3CCN4CCC[C@H]4C3)c2cc1OC1CCCCC1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.56
HTR6 P50406 1/20 0.50
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
ALDH1A1 P00352 1/20 0.44
HTR1D P28221 2/20 0.43
HTR1B P28222 2/20 0.43
OPRM1 P35372 1/20 0.43
OPRK1 P41145 1/20 0.43
OPRL1 P41146 1/20 0.43
HRH3 Q9Y5N1 1/20 0.41
HSD11B1 P28845 1/20 0.41
HTR1A P08908 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
THPO P40225 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014117 1.00 SLC6A4 (0.56) SLC6A4HTR6MTNR1AMTNR1BALDH1A1
SCHEMBL7003242 0.83 SLC6A4 (0.57) SLC6A4HTR6MTNR1AMTNR1BHTR1D
SCHEMBL6995996 0.83 SLC6A4 (0.59) SLC6A4MTNR1AMTNR1BHTR1DHTR1B
SCHEMBL6642008 0.82 HTR1D (0.63) SLC6A4MTNR1AMTNR1BHTR1DHTR1B
SCHEMBL4677184 0.81 HTR1D (0.65) HTR6HTR1DHTR1BHTR1ACYP1A2
SCHEMBL6996942 0.80 SLC6A4 (0.61) SLC6A4ALDH1A1HTR1DHTR1BOPRM1
SCHEMBL8381443 0.80 CYP1A2 (0.63) SLC6A4MTNR1AMTNR1BHTR1DHTR1B
SCHEMBL7011235 0.80 SLC6A4 (0.84) SLC6A4HTR1BOPRM1OPRK1OPRL1
SCHEMBL8385502 0.78 HTR1D (0.51) SLC6A4HTR1DHTR1BHTR1A
SCHEMBL7002497 0.77 SLC6A4 (0.61) SLC6A4HTR1DHTR1BOPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1105393-B1 BICYCLIC PIPERIDINE AND PIPERAZINE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY NPS ALLELIX CORP (CA) 2003-10-01 EP disclosed
US-6251893-B1 TREATING CENTRAL NERVOUS SYSTEM DISORDERS NPS ALLELIX CORP. (CA) 2001-06-26 US disclosed